Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

Clinical trial NCT01276899 · COMPLETED

Trial details

NCT number: NCT01276899
Sponsor: Jewish General Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Triple Negative Breast Cancer

Start date: 2010-09-01
Primary completion: 2015-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.